Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Drug Recalls Topic Center

The Latest

News
OTC Acid Reducer Recalled
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
Three Firms Recall Injections for Sterility Concerns
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
Incorrect Package Insert Prompts Recall
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
More than 30 Injection Products Recalled for Sterility Concerns
04/09/2024
Jolynn Tumolo
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
Class I Recall for Injection
04/05/2024
Jolynn Tumolo
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
OTC Contraceptive Recalled
04/04/2024
Jolynn Tumolo
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp....
04/04/2024
Pharmacy Learning Network
News
Birth Control Pills Recalled
04/04/2024
Jolynn Tumolo
More than 92,000 cartons of Tri-Lo-Sprintec tablets are being recalled by Teva Pharmaceuticals USA because samples of the drug failed to meet dissolution specifications during testing, according to the April 3, 2024, US Food and Drug...
More than 92,000 cartons of Tri-Lo-Sprintec tablets are being recalled by Teva Pharmaceuticals USA because samples of the drug failed to meet dissolution specifications during testing, according to the April 3, 2024, US Food and Drug...
More than 92,000 cartons of...
04/04/2024
Pharmacy Learning Network
News
Anticonvulsant Tablets Recalled
04/04/2024
Jolynn Tumolo
Amneal Pharmaceuticals of New York is recalling 21,452 bottles of divalproex sodium extended-release tablets because samples failed to meet dissolution specifications, according to the April 3, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New York is recalling 21,452 bottles of divalproex sodium extended-release tablets because samples failed to meet dissolution specifications, according to the April 3, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New...
04/04/2024
Pharmacy Learning Network
Poll
Tianeptine and Drug Approval
03/28/2024
03/28/2024
Pharmacy Learning Network
News
Cross-Contamination Prompts Heart Drug Recall
03/27/2024
Jolynn Tumolo
Novitium Pharma is recalling 3940 bottles of digoxin tablets because of cross-contamination with the immunosuppressant mycophenolate mofetil.
Novitium Pharma is recalling 3940 bottles of digoxin tablets because of cross-contamination with the immunosuppressant mycophenolate mofetil.
Novitium Pharma is recalling...
03/27/2024
Pharmacy Learning Network
News
Distributor Recalls Products for Potentially Dangerous Ingredient
03/27/2024
Jolynn Tumolo
Super Chill Products is recalling all lots of Neptune’s Fix Tianeptine Elixir.
Super Chill Products is recalling all lots of Neptune’s Fix Tianeptine Elixir.
Super Chill Products is...
03/27/2024
Pharmacy Learning Network

Newsfeed

News
OTC Acid Reducer Recalled
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
Three Firms Recall Injections for Sterility Concerns
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
Incorrect Package Insert Prompts Recall
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
More than 30 Injection Products Recalled for Sterility Concerns
04/09/2024
Jolynn Tumolo
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
Class I Recall for Injection
04/05/2024
Jolynn Tumolo
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
OTC Contraceptive Recalled
04/04/2024
Jolynn Tumolo
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp....
04/04/2024
Pharmacy Learning Network
News
Birth Control Pills Recalled
04/04/2024
Jolynn Tumolo
More than 92,000 cartons of Tri-Lo-Sprintec tablets are being recalled by Teva Pharmaceuticals USA because samples of the drug failed to meet dissolution specifications during testing, according to the April 3, 2024, US Food and Drug...
More than 92,000 cartons of Tri-Lo-Sprintec tablets are being recalled by Teva Pharmaceuticals USA because samples of the drug failed to meet dissolution specifications during testing, according to the April 3, 2024, US Food and Drug...
More than 92,000 cartons of...
04/04/2024
Pharmacy Learning Network
News
Anticonvulsant Tablets Recalled
04/04/2024
Jolynn Tumolo
Amneal Pharmaceuticals of New York is recalling 21,452 bottles of divalproex sodium extended-release tablets because samples failed to meet dissolution specifications, according to the April 3, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New York is recalling 21,452 bottles of divalproex sodium extended-release tablets because samples failed to meet dissolution specifications, according to the April 3, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New...
04/04/2024
Pharmacy Learning Network
News
Cross-Contamination Prompts Heart Drug Recall
03/27/2024
Jolynn Tumolo
Novitium Pharma is recalling 3940 bottles of digoxin tablets because of cross-contamination with the immunosuppressant mycophenolate mofetil.
Novitium Pharma is recalling 3940 bottles of digoxin tablets because of cross-contamination with the immunosuppressant mycophenolate mofetil.
Novitium Pharma is recalling...
03/27/2024
Pharmacy Learning Network
News
Distributor Recalls Products for Potentially Dangerous Ingredient
03/27/2024
Jolynn Tumolo
Super Chill Products is recalling all lots of Neptune’s Fix Tianeptine Elixir.
Super Chill Products is recalling all lots of Neptune’s Fix Tianeptine Elixir.
Super Chill Products is...
03/27/2024
Pharmacy Learning Network
News
OTC Acid Reducer Recalled
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
Three Firms Recall Injections for Sterility Concerns
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
FDA Collaborates With AbbVie to Track Down Counterfeit Botox Injections
04/16/2024
Danielle Sposato
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA...
04/16/2024
Pharmacy Learning Network
News
Incorrect Package Insert Prompts Recall
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
Resmetirom Superior to Placebo for NASH Resolution and Liver Fibrosis Reduction
04/10/2024
Jolynn Tumolo
In adults with nonalcoholic steatohepatitis (NASH), resmetirom was superior to placebo for the outcomes of NASH resolution and improvement in liver fibrosis by at least one stage, according to a study published in The New England Journal of...
In adults with nonalcoholic steatohepatitis (NASH), resmetirom was superior to placebo for the outcomes of NASH resolution and improvement in liver fibrosis by at least one stage, according to a study published in The New England Journal of...
In adults with nonalcoholic...
04/10/2024
Pharmacy Learning Network
News
More than 30 Injection Products Recalled for Sterility Concerns
04/09/2024
Jolynn Tumolo
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
Outcomes Worse in Adults Hospitalized With RSV than Influenza
04/09/2024
Jolynn Tumolo
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with...
04/09/2024
Pharmacy Learning Network
News
Class I Recall for Injection
04/05/2024
Jolynn Tumolo
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
Sanofi's Settlement: Navigating the Zantac Cancer Link Legal Saga
04/04/2024

Danielle Sposato

Danielle Sposato
On April 3, 2024, Sanofi agreed to settle its 4,000 lawsuits prompted by the discontinued Zantac due to its link to cancer, according to a recent Reuters article. The plaintiffs in the case claim Zantac causes cancer due to the active...
On April 3, 2024, Sanofi agreed to settle its 4,000 lawsuits prompted by the discontinued Zantac due to its link to cancer, according to a recent Reuters article. The plaintiffs in the case claim Zantac causes cancer due to the active...
On April 3, 2024, Sanofi agreed...
04/04/2024
Pharmacy Learning Network
News
OTC Contraceptive Recalled
04/04/2024
Jolynn Tumolo
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp....
04/04/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement